Publications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Salud Mental (11)

2024

  1. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

2023

  1. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

  2. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder

    Biomolecules, Vol. 13, Núm. 2

2021

  1. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  2. Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates

    Neuroscience, Vol. 467, pp. 91-109

  3. Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity

    European Journal of Medicinal Chemistry, Vol. 209

  4. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  5. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  6. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

2018

  1. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 81, pp. 236-242